Martin Samuel Bates

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 29% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Martin Samuel Bates's trades of Celldex Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
313.11
Quantity 22,767
Value US$4,285,800
Transaction date
Proposed sale
Price
34.05
Quantity 35,000
Value US$1,191,771
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-18 2024-06-14
S Sale
99,264 +21.8%
123.86
US$571,981 		99,264 +21.8% 123.86 US$571,981
2024-06-14 2024-06-14
PrS Proposed sale
22,767
313.11
US$4,285,800 		22,767 313.11 US$4,285,800
2024-06-03 2024-05-30
S Sale
3,350 +4.0%
221.00
US$582,887 		3,350 +4.0% 221.00 US$582,887
2024-05-30 2024-05-30
PrS Proposed sale
35,000
34.05
US$1,191,771 		35,000 34.05 US$1,191,771
2022-08-15 2022-08-12
S Sale
1,221 -4.8%
34.62
US$42,272 		1,221 -4.8% 34.62 US$42,272
2022-08-15 2022-08-12
S Sale
2,065 -7.5%
35.38
US$73,053 		2,065 -7.5% 35.38 US$73,053
2022-08-15 2022-08-12
S Sale
14,261 -34.0%
36.76
US$524,304 		14,261 -34.0% 36.76 US$524,304
2022-08-15 2022-08-11
S Sale
2,453 -9.1%
37.04
US$90,856 		2,453 -9.1% 37.04 US$90,856
2021-11-17 2021-11-15
PlS Planned sale
2,048 -7.1%
42.27
US$86,569 		2,048 -7.1% 42.27 US$86,569
2021-11-17 2021-11-15
PlS Planned sale
7,452 -20.5%
43.92
US$327,314 		7,452 -20.5% 43.92 US$327,314
2020-06-10 2020-06-09
PP Planned purchase
9,750 +989.8%
3.05
US$29,738 		9,750 +989.8% 3.05 US$29,738